Net Zero Infrastructure PLC - special purpose acquisition company focused on renewable or clean energy technology companies - Completes third-party independent valuation of the intellectual property assets of QuiaPEG Pharmaceuticals AB. Says that the assets are estimated to be worth around £30 million. QuiaPeg is a drug development company based on the patented drug delivery platform, Uni-Qleaver.
This follows an announcement by Net Zero in February, when the company said that it had signed a non-binding letter of intent with QuiaPEG Pharmaceuticals Holding AD for a deal that would constitute a reverse takeover. Net Zero says work will continue on the prospectus and finalising the license agreement, so the transaction can be completed in the coming months.
Net Zero shares are suspended from trading on the London Main Market.
Copyright 2024 Alliance News Ltd. All Rights Reserved.
